St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the rest of the immune system to the presence of cancer—and how restoring their ...
Two years ago, the Emerald-1 trial hit its primary endpoint, showing that a cocktail of Imfinzi, Avastin and TACE reduced the ...
Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...
T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.
A young woman with advanced, inoperable tongue cancer experienced a rare recovery after immunotherapy and chemotherapy.
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has reached a significant ...
A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July ...
Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This ...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), th cancer immunotherapy developer, has named David Schilansky as ...
Spencer Laird’s first colon cancer diagnosis came at 26. The Swansea man was told surgery was a success. But a routine scan ...
A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results